Alexandre Pieri Chiari
Mesa 4 - Presidente da Mesa: Dr. Lucas Nogueira
| Artigo | Autor(es) | Referência |
|---|---|---|
| Androgen receptor-dependent and -independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles. | Hoang David T, Iczkowski Kenneth A, Kilari Deepak, See William, Nevalainen Marja T | Oncotarget. 2017 Jan; 8(Jan):3724-3745. doi: 10.18632/oncotarget.12554. pii: . |
| EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer. | Cornford Philip, Bellmunt Joaquim, Bolla Michel, Briers Erik, De Santis Maria, Gross Tobias, Henry Ann M, Joniau Steven, Lam Thomas B, Mason Malcolm D, van der Poel Henk G, van der Kwast Theo H, Rouvière Olivier, Wiegel Thomas, Mottet Nicolas | European urology. 2017 04; 71(04):630-642. doi: 10.1016/j.eururo.2016.08.002. pii: S0302-2838(16)30469-9. |
| Galeterone for the treatment of advanced prostate cancer: the evidence to date. | Bastos Diogo A, Antonarakis Emmanuel S | Drug design, development and therapy. 2016 ; 10():2289-97. doi: 10.2147/DDDT.S93941. pii: . |
| Novel Insights into Molecular Indicators of Response and Resistance to Modern Androgen-Axis Therapies in Prostate Cancer. | Silberstein John L, Taylor Maritza N, Antonarakis Emmanuel S | Current urology reports. 2016 Apr; 17(Apr):29. doi: 10.1007/s11934-016-0584-4. pii: . |
| Role of taxanes in advanced prostate cancer. | Cassinello J, Carballido Rodríguez J, Antón Aparicio L | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2016 Oct; 18(Oct):972-80. doi: 10.1007/s12094-015-1480-y. pii: . |
| Statin derivatives as therapeutic agents for castration-resistant prostate cancer. | Ingersoll Matthew A, Miller Dannah R, Martinez October, Wakefield C Brent, Hsieh Kuan-Chan, Simha M Vijaya, Kao Chai-Lin, Chen Hui-Ting, Batra Surinder K, Lin Ming-Fong | Cancer letters. 2016 12; 383(12):94-105. doi: 10.1016/j.canlet.2016.09.008. pii: S0304-3835(16)30550-X. |
| Targeting the N-Terminal Domain of the Androgen Receptor: A New Approach for the Treatment of Advanced Prostate Cancer. | Antonarakis Emmanuel S, Chandhasin Chandtip, Osbourne Erica, Luo Jun, Sadar Marianne D, Perabo Frank | The oncologist. 2016 12; 21(12):1427-1435. |
| The safety and efficacy of radium-223 dichloride for the treatment of advanced prostate cancer. | Wilson James M, Parker Christopher | Expert review of anticancer therapy. 2016 Sep; 16(Sep):911-8. doi: 10.1080/14737140.2016.1222273. pii: . |